Christopher R. Friese, PhD, RN, AOCN®, FAAN, is the 2015 recipient of the Rose Mary Carroll-Johnson Distinguished Award for Consistent Contribution to the Nursing Literature. Friese's work has been praised for its interdisciplinary nature and appears across diverse scientific journals., He is an assistant professor at the University of Michigan School of Nursing in Ann Arbor.
Search Results for "newsroom news ons announces distinguished award contribution nursing literature"
ONS Announces Winner of Distinguished Award for Contribution to Nursing Literature
Thursday, March 26, 2015
Christopher R. Friese, PhD, RN, AOCN®, FAAN, of Ann Arbor, MI, is the recipient of the Oncology Nursing Society (ONS) 2015 Rose Mary Carroll-Johnson Distinguished Award for Consistent Contribution to the Nursing Literature. This award recognizes the impact that he has made on the oncology nursing profession through his high-quality research publications, his dissemination of findings for policymakers and practitioners, and his efforts to support the professional development of colleagues. He will be honored for the award at the opening ceremony of the ONS 40th Annual Congress in Orlando, FL, on April 23, 2015.
Friese is an assistant professor at the University of Michigan School of Nursing in Ann Arbor. Since he began his career in 1997, he has conducted research to measure and improve the quality and safety of cancer care delivery. His 51 peer-reviewed manuscripts have been published in the Oncology Nursing Forum, Clinical Journal of Oncology Nursing, BMJ Quality and Safety, Cancer, Cancer Nursing, Health Services Research, and Medical Care. A hallmark of his publications is their interdisciplinary nature, from his co-authors and collaborators to the diverse scientific journals in which he has been published.
“Receiving this award from ONS means a great deal to me and my research collaborators,” said Friese. “I am glad that my publications that examine quality of cancer nursing care are valued by my fellow oncology nurses. I am especially grateful to participants in our research studies, who make our publications possible.”
Friese received his bachelor of science in nursing degree and PhD from the University of Pennsylvania School of Nursing in Philadelphia. He completed a post-doctoral fellowship at the Dana-Farber Cancer Center and Harvard School of Public Health in Boston, MA. He is an active member of the Ann Arbor and Metro Detroit Chapters of ONS, the ONS Research Special Interest Group, and the American Society of Clinical Oncology, and he is also a fellow in the American Academy of Nursing. He currently directs the DEFENS Study, a four-year, $2.3-million study to understand and improve the safety of chemotherapy administration. In addition to his appointment in the School of Nursing, Friese is a core member of both the Comprehensive Cancer Center and the Institute for Healthcare Policy and Innovation at the University of Michigan.
ONS is a professional association of more than 35,000 members committed to promoting excellence in oncology nursing and the transformation of cancer care. Since 1975, ONS has provided a professional community for oncology nurses, developed evidence-based education programs and treatment information, and advocated for patient care, all in an effort to improve quality of life and outcomes for patients with cancer and their families.
ONS Names New Chief Executive Officer
Friday, July 11, 2014
ONS is pleased to announce that Brenda Marion Nevidjon, RN, MSN, FAAN, is named as its new chief executive officer (CEO), effective September 1.
story and image
The Oncology Nursing Society (ONS) today named Brenda Marion Nevidjon, RN, MSN, FAAN, as its new chief executive officer (CEO), effective September 1.
“We are excited to welcome Brenda as the new ONS CEO. Her distinguished career and leadership skill set will position ONS for the future within a complex and changing healthcare system, while achieving the ONS mission to promote excellence in oncology nursing and quality cancer care. It is an exciting time for ONS and the ONS Board of Directors,” said ONS President Margaret Barton-Burke, PhD, RN, FAAN.
“I am honored to be selected as the ONS CEO,” Nevidjon said. “I look forward to working with the Board, staff, members, and the larger cancer care community as we transform the provision of cancer care in a changing healthcare environment.”
Nevidjon is currently a professor at the Duke University School of Nursing and coordinator of the Systems Division, which includes the nursing informatics, nursing education, and nursing and healthcare leadership graduate majors. She has had an extraordinary nursing career of leadership in service and education and was the first nurse and first woman to be chief operating officer of Duke University Hospital. Through diverse clinical and administrative experiences in Canada, Switzerland, and the United States, she has devoted her energy to bridging practice settings and academic environments to advance patient care, creating innovative work environments, promoting scholarship in practitioners, and developing leaders.
She has helped develop professional nursing organizations at the local, national, and international levels and has made lasting contributions to ONS. Nevidjon is a past president of ONS and the ONS Foundation, has completed a term on the Institute of Medicine’s National Cancer Policy Forum Board, and has served on other cancer-related boards, most recently the Association of Community Cancer Centers and the International Society of Nurses in Cancer Care.
With extensive publications in the nursing literature, Nevidjon is regarded as a mentor for nurses to develop their power and voice through publication. Her diverse contributions include two volumes of oncology nurse narratives as well as books, articles, and chapters on oncology and administrative topics, such as the role of advanced practice nurses and the nursing shortage. She consults with organizations related to work culture, team building, and leadership development.
Nevidjon received the Duke School of Nursing Distinguished Alumni Award, the ONS Trish Greene Quality of Life Memorial Lectureship, and the American Nursing Association’s Honorary Recognition Award for her sustained contributions to the nursing profession. She is a graduate of the inaugural class of the Robert Wood Johnson Nurse Executive Program and the Johnson & Johnson–Wharton Fellows Program in Management for Nurse Executives and is a fellow in the American Academy of Nursing.